BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gumusova S, Sunbul M, Leblebicioglu H. Ebola virus disease and the veterinary perspective. Ann Clin Microbiol Antimicrob 2015;14:30. [PMID: 26018030 DOI: 10.1186/s12941-015-0089-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Tell JG, Coller BG, Dubey SA, Jenal U, Lapps W, Wang L, Wolf J. Environmental Risk Assessment for rVSVΔG-ZEBOV-GP, a Genetically Modified Live Vaccine for Ebola Virus Disease. Vaccines (Basel) 2020;8:E779. [PMID: 33352786 DOI: 10.3390/vaccines8040779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kieh MD, Cho EM, Myles IA. Contrasting academic and lay press print coverage of the 2013-2016 Ebola Virus Disease outbreak. PLoS One 2017;12:e0179356. [PMID: 28640889 DOI: 10.1371/journal.pone.0179356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
3 Kwofie SK, Broni E, Teye J, Quansah E, Issah I, Wilson MD, Miller WA 3rd, Tiburu EK, Bonney JHK. Pharmacoinformatics-based identification of potential bioactive compounds against Ebola virus protein VP24. Comput Biol Med 2019;113:103414. [PMID: 31536833 DOI: 10.1016/j.compbiomed.2019.103414] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]